一种多价 mRNA-LNP 疫苗可预防 感染。
A multivalent mRNA-LNP vaccine protects against infection.
机构信息
Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Penn Institute for RNA Innovation, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
出版信息
Science. 2024 Oct 4;386(6717):69-75. doi: 10.1126/science.adn4955. Epub 2024 Oct 3.
Abstract
infection (CDI) is an urgent public health threat with limited preventative options. In this work, we developed a messenger RNA (mRNA)-lipid nanoparticle (LNP) vaccine targeting toxins and virulence factors. This multivalent vaccine elicited robust and long-lived systemic and mucosal antigen-specific humoral and cellular immune responses across animal models, independent of changes to the intestinal microbiota. Vaccination protected mice from lethal CDI in both primary and recurrent infection models, and inclusion of non-toxin cellular and spore antigens improved decolonization of toxigenic from the gastrointestinal tract. Our studies demonstrate mRNA-LNP vaccine technology as a promising platform for the development of novel therapeutics with potential for limiting acute disease and promoting bacterial decolonization.
摘要
感染（CDI）是一种紧迫的公共健康威胁，预防选择有限。在这项工作中，我们开发了一种针对毒素和毒力因子的信使 RNA（mRNA）-脂质纳米颗粒（LNP）疫苗。这种多价疫苗在动物模型中引发了强大且持久的全身和粘膜抗原特异性体液和细胞免疫反应，而与肠道微生物群的变化无关。疫苗接种可在原发性和复发性感染模型中保护小鼠免受致命的 CDI，并且包含非毒性细胞和孢子抗原可改善从胃肠道中消除产毒 。我们的研究表明，mRNA-LNP 疫苗技术是开发新型 治疗方法的有前途的平台，具有限制急性疾病和促进细菌去定植的潜力。
相似文献
1
A multivalent mRNA-LNP vaccine protects against infection.一种多价 mRNA-LNP 疫苗可预防 感染。
Science. 2024 Oct 4;386(6717):69-75. doi: 10.1126/science.adn4955. Epub 2024 Oct 3.
2
Systemic antibody responses induced by a two-component Clostridium difficile toxoid vaccine protect against C. difficile-associated disease in hamsters.两组分艰难梭菌类毒素疫苗诱导的系统抗体应答可预防仓鼠艰难梭菌相关性疾病。
J Med Microbiol. 2013 Sep;62(Pt 9):1394-1404. doi: 10.1099/jmm.0.056796-0. Epub 2013 Mar 21.
3
Defining the Roles of TcdA and TcdB in Localized Gastrointestinal Disease, Systemic Organ Damage, and the Host Response during Clostridium difficile Infections.确定艰难梭菌感染期间TcdA和TcdB在局部胃肠道疾病、全身器官损伤及宿主反应中的作用。
mBio. 2015 Jun 2;6(3):e00551. doi: 10.1128/mBio.00551-15.
4
Oral Immunization with Nontoxigenic Clostridium difficile Strains Expressing Chimeric Fragments of TcdA and TcdB Elicits Protective Immunity against C. difficile Infection in Both Mice and Hamsters.口服表达 TcdA 和 TcdB 嵌合片段的无毒型艰难梭菌菌株可诱导小鼠和仓鼠产生针对艰难梭菌感染的保护性免疫。
Infect Immun. 2018 Oct 25;86(11). doi: 10.1128/IAI.00489-18. Print 2018 Nov.
5
Genomic and Phenotypic Characterization of the Nontoxigenic Clostridioides difficile Strain CCUG37785 and Demonstration of Its Therapeutic Potential for the Prevention of C. difficile Infection.非产毒艰难梭菌 CCUG37785 株的基因组和表型特征及其预防艰难梭菌感染的治疗潜力的研究
Microbiol Spectr. 2022 Apr 27;10(2):e0178821. doi: 10.1128/spectrum.01788-21. Epub 2022 Mar 22.
6
A novel fusion protein containing the receptor binding domains of C. difficile toxin A and toxin B elicits protective immunity against lethal toxin and spore challenge in preclinical efficacy models.一种新型融合蛋白，包含艰难梭菌毒素 A 和毒素 B 的受体结合结构域，在临床前疗效模型中可引发针对致死毒素和孢子挑战的保护性免疫。
Vaccine. 2012 Jun 13;30(28):4249-58. doi: 10.1016/j.vaccine.2012.04.045. Epub 2012 Apr 23.
7
Development of an Effective Nontoxigenic Clostridioides difficile-Based Oral Vaccine against C. difficile Infection.开发一种有效的无细胞毒素艰难梭菌口服疫苗以预防艰难梭菌感染。
Microbiol Spectr. 2022 Jun 29;10(3):e0026322. doi: 10.1128/spectrum.00263-22. Epub 2022 May 18.
8
A chimeric toxin vaccine protects against primary and recurrent Clostridium difficile infection.嵌合毒素疫苗可预防原发性和复发性艰难梭菌感染。
Infect Immun. 2012 Aug;80(8):2678-88. doi: 10.1128/IAI.00215-12. Epub 2012 May 21.
9
Clostridium difficile chimeric toxin receptor binding domain vaccine induced protection against different strains in active and passive challenge models.艰难梭菌嵌合毒素受体结合域疫苗在主动和被动攻击模型中诱导了针对不同菌株的保护作用。
Vaccine. 2017 Jul 24;35(33):4079-4087. doi: 10.1016/j.vaccine.2017.06.062. Epub 2017 Jun 29.
10
Toll-like receptor 5-dependent immunogenicity and protective efficacy of a recombinant fusion protein vaccine containing the nontoxic domains of Clostridium difficile toxins A and B and Salmonella enterica serovar typhimurium flagellin in a mouse model of Clostridium difficile disease.含艰难梭菌毒素 A 和 B 无毒结构域以及鼠伤寒沙门氏菌鞭毛蛋白的重组融合蛋白疫苗在艰难梭菌病小鼠模型中的 Toll 样受体 5 依赖性免疫原性和保护效力。
Infect Immun. 2013 Jun;81(6):2190-6. doi: 10.1128/IAI.01074-12. Epub 2013 Apr 1.
引用本文的文献
1
Harnessing the Potential of mRNA Vaccines Against Infectious Diseases.利用mRNA疫苗对抗传染病的潜力。
Microb Biotechnol. 2025 Aug;18(8):e70212. doi: 10.1111/1751-7915.70212.
2
toxin A and toxin B inhibit toxin-specific adaptive immune responses through glucosyltransferase-dependent activity.毒素A和毒素B通过依赖葡萄糖基转移酶的活性抑制毒素特异性适应性免疫反应。
bioRxiv. 2025 Aug 2:2025.07.30.667646. doi: 10.1101/2025.07.30.667646.
3
Engaging Broader Stakeholders to Accelerate Group A Vaccine Development.吸引更广泛的利益相关者以加速A群疫苗的研发。
Vaccines (Basel). 2025 Jul 7;13(7):734. doi: 10.3390/vaccines13070734.
4
Challenges and opportunities in mRNA vaccine development against bacteria.抗细菌mRNA疫苗开发中的挑战与机遇。
Nat Microbiol. 2025 Aug;10(8):1816-1828. doi: 10.1038/s41564-025-02070-z. Epub 2025 Jul 29.
5
An mRNA vaccine encoding five conserved Group A Streptococcus antigens.一种编码五种保守A群链球菌抗原的信使核糖核酸疫苗。
Nat Commun. 2025 Jul 1;16(1):5439. doi: 10.1038/s41467-025-60580-0.
6
The interplay between host immunity and infection.宿主免疫与感染之间的相互作用。
mBio. 2025 Aug 13;16(8):e0356224. doi: 10.1128/mbio.03562-24. Epub 2025 Jul 1.
7
Pore formation by the CDTb component of the Clostridioides difficile binary toxin is Ca-dependent.艰难梭菌二元毒素的CDTb组分形成孔道依赖于钙离子。
Commun Biol. 2025 Jun 9;8(1):901. doi: 10.1038/s42003-025-08343-x.
8
Nucleic acid vaccines: innovations, efficacy, and applications in at-risk populations.核酸疫苗：创新、疗效及在高危人群中的应用
Front Immunol. 2025 May 14;16:1584876. doi: 10.3389/fimmu.2025.1584876. eCollection 2025.
9
Evaluation of the Potency of the First Commercial Vaccine for Infection in Piglets and Comparison with the Humoral Response in Rabbits.评估首款用于仔猪感染的商业疫苗的效力及其与家兔体液免疫反应的比较。
Vaccines (Basel). 2025 Apr 22;13(5):438. doi: 10.3390/vaccines13050438.
10
Against Infection: An Update on Vaccine Development.抗感染：疫苗研发的最新进展
Toxins (Basel). 2025 May 1;17(5):222. doi: 10.3390/toxins17050222.
本文引用的文献
1
Clostridioides difficile toxin B subverts germinal center and antibody recall responses by stimulating a drug-treatable CXCR4-dependent mechanism.艰难梭菌毒素 B 通过刺激一种可药物治疗的 CXCR4 依赖性机制来颠覆生发中心和抗体回忆反应。
Cell Rep. 2024 May 28;43(5):114245. doi: 10.1016/j.celrep.2024.114245. Epub 2024 May 17.
2
Nonsteroidal anti-inflammatory drugs sensitize epithelial cells to toxin-mediated mitochondrial damage.非甾体抗炎药使上皮细胞对毒素介导的线粒体损伤敏感。
Sci Adv. 2023 Jul 21;9(29):eadh5552. doi: 10.1126/sciadv.adh5552. Epub 2023 Jul 19.
3
ElasticBLAST: accelerating sequence search via cloud computing.ElasticBLAST：通过云计算加速序列搜索。
BMC Bioinformatics. 2023 Mar 26;24(1):117. doi: 10.1186/s12859-023-05245-9.
4
A single-dose F1-based mRNA-LNP vaccine provides protection against the lethal plague bacterium.一针剂基于 F1 的 mRNA-LNP 疫苗为致命鼠疫菌提供保护。
Sci Adv. 2023 Mar 10;9(10):eadg1036. doi: 10.1126/sciadv.adg1036. Epub 2023 Mar 8.
5
A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes.一种针对所有已知流感病毒亚型的多价核苷修饰 mRNA 疫苗。
Science. 2022 Nov 25;378(6622):899-904. doi: 10.1126/science.abm0271. Epub 2022 Nov 24.
6
Enterococci enhance Clostridioides difficile pathogenesis.肠球菌增强艰难梭菌的发病机制。
Nature. 2022 Nov;611(7937):780-786. doi: 10.1038/s41586-022-05438-x. Epub 2022 Nov 16.
7
Development of a pentavalent broadly protective nucleoside-modified mRNA vaccine against influenza B viruses.开发一种针对乙型流感病毒的五价广泛保护性核苷修饰 mRNA 疫苗。
Nat Commun. 2022 Aug 9;13(1):4677. doi: 10.1038/s41467-022-32149-8.
8
Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses.脂质纳米颗粒通过诱导强烈的滤泡辅助性T细胞和体液反应来增强mRNA疫苗和蛋白质亚单位疫苗的效力。
Immunity. 2022 Jun 14;55(6):1136-1138. doi: 10.1016/j.immuni.2022.05.007.
9
Bakta: rapid and standardized annotation of bacterial genomes via alignment-free sequence identification.Bakta：通过无比对序列鉴定实现细菌基因组的快速标准化注释。
Microb Genom. 2021 Nov;7(11). doi: 10.1099/mgen.0.000685.
10
Rapid induction of antigen-specific CD4 T cells is associated with coordinated humoral and cellular immunity to SARS-CoV-2 mRNA vaccination.快速诱导抗原特异性 CD4 T 细胞与对 SARS-CoV-2 mRNA 疫苗接种的协调体液和细胞免疫有关。
Immunity. 2021 Sep 14;54(9):2133-2142.e3. doi: 10.1016/j.immuni.2021.08.001. Epub 2021 Aug 13.
Zotero 插件